Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days
Phase of Trial: Phase II
Latest Information Update: 24 May 2018
At a glance
- Drugs Insulin detemir (Primary) ; Insulin
- Indications Alzheimer's disease; Mild cognitive impairment
- Focus Pharmacodynamics
- Acronyms SL120
- 05 Jan 2018 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 30 Nov 2016 Planned End Date changed from 1 Sep 2015 to 1 Mar 2017.